Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Neth J Med ; 74(1): 5-15, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26819356

RESUMO

BACKGROUND: Percutaneous renal denervation (RDN) has recently been introduced as a treatment for therapy-resistant hypertension. Also, it has been suggested that RDN may be beneficial for other conditions characterised by increased sympathetic nerve activity. There are still many uncertainties with regard to efficacy, safety, predictors for success and long-term effects. To answer these important questions, we initiated a Dutch RDN registry aiming to collect data from all RDN procedures performed in the Netherlands. METHODS: The Dutch RDN registry is an ongoing investigator-initiated, prospective, multicentre cohort study. Twenty-six Dutch hospitals agreed to participate in this registry. All patients who undergo RDN, regardless of the clinical indication or device that is used, will be included. Data are currently being collected on eligibility and screening, treatment and follow-up. RESULTS: Procedures have been performed since August 2010. At present, data from 306 patients have been entered into the database. The main indication for RDN was hypertension (n = 302, 99%). Patients had a mean office blood pressure of 177/100 (±29/16) mmHg with a median use of three (range 0-8) blood pressure lowering drugs. Mean 24-hour blood pressure before RDN was 157/93 (±18/13) mmHg. RDN was performed with different devices, with the Simplicity™ catheter currently used most frequently. CONCLUSION: Here we report on the rationale and design of the Dutch RDN registry. Enrolment in this investigator-initiated study is ongoing. We present baseline characteristics of the first 306 participants.


Assuntos
Hipertensão/cirurgia , Sistema de Registros , Artéria Renal/cirurgia , Simpatectomia/estatística & dados numéricos , Idoso , Anti-Hipertensivos/uso terapêutico , Pressão Sanguínea , Feminino , Humanos , Hipertensão/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Países Baixos/epidemiologia , Período Pré-Operatório , Estudos Prospectivos , Artéria Renal/inervação , Simpatectomia/métodos , Tempo , Resultado do Tratamento
2.
Int J Cardiol ; 132(1): 59-65, 2009 Feb 06.
Artigo em Inglês | MEDLINE | ID: mdl-18241941

RESUMO

AIMS: To assess safety and efficacy of off-site percutaneous coronary intervention (PCI) in The Dutch invasive cardiovascular system. METHODS AND RESULTS: Descriptive single centre registry of elective and emergency PCI. Setting is a Dutch community hospital, 40 km north of Amsterdam, with an adherent population of 400,000 people. A Clinical follow up of Major Adverse Cardiac and Cerebral Events (MACCE) at 30 days post PCI is performed. The total number of participants eligible for PCI was 781 of whom 545 were men and 236 women. During a two-year period 781 PCI's were performed of which 298 were emergency and 483 elective. Acute complications occurred in 2.1% of participants. MACCE-free was 86.9% in the group with AMI and 95.8% in the elective group. CONCLUSIONS: Off-site PCI is feasible and safe in The Netherlands on the condition that specific key factors for success are taken into consideration.


Assuntos
Angioplastia Coronária com Balão/estatística & dados numéricos , Hospitais Comunitários/estatística & dados numéricos , Infarto do Miocárdio/terapia , Angioplastia Coronária com Balão/efeitos adversos , Angioplastia Coronária com Balão/normas , Clopidogrel , Estudos de Viabilidade , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/tratamento farmacológico , Infarto do Miocárdio/epidemiologia , Países Baixos/epidemiologia , Inibidores da Agregação Plaquetária/uso terapêutico , Sistema de Registros , Fatores de Risco , Segurança , Ticlopidina/análogos & derivados , Ticlopidina/uso terapêutico , Resultado do Tratamento
4.
Eur J Heart Fail ; 4(4): 419-30, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12167379

RESUMO

BACKGROUND: increasing evidence supports the existence of left ventricular diastolic dysfunction as an important cause of congestive heart failure, present in up to 40% of heart failure patients. AIM: to review the pathophysiology of LV diastolic dysfunction and diastolic heart failure and the currently available methods to diagnose these disorders. RESULTS: for diagnosing LV diastolic dysfunction, invasive hemodynamic measurements are the gold standard. Additional exercise testing with assessment of LV volumes and pressures may be of help in detecting exercise-induced elevation of filling pressures because of diastolic dysfunction. However, echocardiography is obtained more easily, and will remain the most often used method for diagnosing diastolic heart failure in the coming years. MRI may provide noninvasive determination of LV three-dimensional motion during diastole, but data on correlation of MRI data with clinical findings are scant, and possibilities for widespread application are limited at this moment. CONCLUSIONS: in the forthcoming years, optimal diagnostic and therapeutic strategies for patients with primary diastolic heart failure have to be developed. Therefore, future heart failure trials should incorporate patients with diastolic heart failure, describing precise details of LV systolic and diastolic function in their study populations.


Assuntos
Diástole/fisiologia , Insuficiência Cardíaca/diagnóstico , Disfunção Ventricular Esquerda/diagnóstico , Ecocardiografia , Teste de Esforço , Insuficiência Cardíaca/fisiopatologia , Hemodinâmica/fisiologia , Humanos , Imageamento por Ressonância Magnética , Contração Miocárdica/fisiologia , Disfunção Ventricular Esquerda/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...